LY
Recent News (4)
-
Lycia Therapeutics closes $365 million upsized IPO Lycia Therapeutics closes $365 million upsized IPO
-
Lycia Therapeutics Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares SOUTH SAN FRANCISCO, Calif., Oct. 26, 2026 (GLOBE NEWSWIRE) -- Lycia Therapeutics, Inc. (“Lycia”) (Nasdaq: LYCA), a clinical-stage biotechnology company focused on the discovery and development of n…
-
Lycia Therapeutics stock surges in IPO debut after pricing about $317.5M offering Lycia Therapeutics stock surges in IPO debut after pricing about $317.5M offering Quartz
- Lycia Therapeutics surges in debut following upsized $317.5M IPO Lycia Therapeutics surges in debut following upsized $317.5M IPO